Address: 37-45, Quai du Président Roosevelt, 92445 Issy-les-Moulineaux Cedex, Paris, France
Tel: +33 (0)1 79 41 29 00
Lundbeck is one of Denmark’s most research-intensive enterprises. We employ a total of 1,100 highly-trained specialists in our research and development units. Each year, Lundbeck ploughs back more than 20% of its revenue into research and development.
In France, Lundbeck has recently moved into new facilities and generates 225 million Euro in sales. Already active in clinical trials in over 110 hospital units, in 2008 Lundbeck acquired long-time supplier Elaiapharm in the south of France to support its overall operations and thus further increasing their presence in the ‘Hexagon’.
Products and services
Centeral Nervous System:
Ebixa (Alzheimer’s disease)
Azilect (Parkinson’s disease)
Xenazine (chorea associated with Huntington’s disease)
Circadin (sleep disorders)